Luo Changqin, He Qingmin, Yang Xiaocui
Department of Gastroenterology, Ankang Central Hospital, Ankang, Shaanxi, China.
Henan Key Laboratory of Helicobacter Pylori, Microbiota and Gastrointestinal Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Front Med (Lausanne). 2024 Nov 27;11:1445228. doi: 10.3389/fmed.2024.1445228. eCollection 2024.
This paper reports a case of pseudolithiasis caused by the use of ceftriaxone sodium. The patient, a 54-year-old female, presented with intermittent abdominal pain and distension for 1 month. Initial ultrasonography showed no abnormalities. However, after receiving ceftriaxone sodium treatment for an upper respiratory tract infection, she developed discomfort in the right upper abdomen. A CT scan subsequently diagnosed her with gallbladder stones. Six weeks after discontinuing the medication, a follow-up examination revealed the disappearance of the stones, confirming the diagnosis of drug-induced pseudolithiasis. Through a literature review, this paper summarizes the mechanism, clinical manifestations, diagnostic methods, and treatment recommendations of ceftriaxone sodium-induced pseudolithiasis, providing a reference for clinical safe medication use.
本文报道了1例因使用头孢曲松钠引起的假性结石病例。患者为54岁女性,出现间歇性腹痛和腹胀1个月。最初的超声检查未发现异常。然而,在接受头孢曲松钠治疗上呼吸道感染后,她出现了右上腹不适。随后的CT扫描诊断她患有胆囊结石。停药6周后,随访检查显示结石消失,证实为药物性假性结石。通过文献复习,本文总结了头孢曲松钠所致假性结石的机制、临床表现、诊断方法及治疗建议,为临床安全用药提供参考。